Abiomed, Inc.: First Patient in Japan Treated with Impella 5.5 with SmartAssist

5,000 Patients Treated Globally The versatility and innovation of Abiomed's (NASDAQ: ABMD) Impella 5.5 with SmartAssist, a minimally-invasive forward flow heart pump, is leading to continued adoption

Related Keywords

Japan ,Osaka ,United States ,Massachusetts ,Jenny Leary ,Todd Trapp ,Yoshiki Sawa ,Mani Daneshmand ,Itsuki Shinohara ,Us Communications ,Drug Administration ,Exchange Commission ,Surgeons At Osaka Police Hospital ,Abiomed ,Emory University Hospital In Atlanta ,Emory University Hospital ,Abiomed Inc ,Osaka Police Hospital ,Business Wire ,Osaka Police ,Tamer Attia ,Emory University ,Impella Connect ,States Media ,Public Relations ,Chief Financial Officer ,First ,Patient ,Reated ,Impella ,Martassist ,